Literature DB >> 12820745

Screening for basic drugs in 2-mL urine samples by dual-plate overpressured layer chromatography and comparison with gas chromatography-mass spectrometry.

Anna Pelander1, Ilkka Ojanperä, Johanna Sistonen, Ilpo Rasanen, Erkki Vuori.   

Abstract

A dual-plate overpressured layer chromatography (OPLC) method was evaluated for broad-scale screening of basic drugs in 2-mL autopsy urine samples. Extraction was carried out by mixed-mode solid-phase extraction, and identification was based on automated comparison of corrected Rf values (hRfc) and in situ UV spectra with library values by dedicated software. The day-to-day precision of hRfc values was good in both OPLC1 and OPLC2 systems with median relative standard deviations of 2.4% and 3.4%, respectively. Both Rf and hRfc values were independent of the amount of analyte (0.5-10 microg) applied to the plate. Detection limits were determined for 47 drug substances in 2-mL urine samples, and they varied between 0.05 and 3.5 mg/L with a median of 1.0 mg/L. The performance of OPLC was evaluated by analyzing 30 autopsy urine samples by both OPLC and gas chromatography-mass spectrometry (GC-MS). The majority of findings by OPLC were in agreement with GC-MS. Some substances with low concentrations were not detected by OPLC, whereas GC-MS failed to detect a few polar substances. The OPLC method thus provides an alternative for current planar and column liquid chromatographic drug screening methods with the possibility of lowering detection limits by using a larger sample size.

Mesh:

Substances:

Year:  2003        PMID: 12820745     DOI: 10.1093/jat/27.4.226

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  1 in total

1.  Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning.

Authors:  Margareeta Häkkinen; Terhi Launiainen; Erkki Vuori; Ilkka Ojanperä
Journal:  Eur J Clin Pharmacol       Date:  2011-09-17       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.